Aura Biosciences, Inc.

AURA Nasdaq CIK: 0001501796

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 80 GUEST STREET, BOSTON, MA, 02135
Mailing Address 80 GUEST STREET, BOSTON, MA, 02135
Phone (617)500-8864
Fiscal Year End 1231
EIN 320271970

Financial Overview

FY2024

-$76.41M
Net Income
$255.07M
Total Assets
$30.53M
Total Liabilities
$225.85M
Stockholders' Equity
$41.06M
Cash & Equivalents
$-1.75
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
4 Insider stock transaction report January 20, 2026 View on SEC
4 Insider stock transaction report January 20, 2026 View on SEC
4 Insider stock transaction report November 17, 2025 View on SEC
10-Q Quarterly financial report November 13, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
4 Insider stock transaction report October 29, 2025 View on SEC
4 Insider stock transaction report October 29, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) October 17, 2025 View on SEC
4 Insider stock transaction report October 16, 2025 View on SEC

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.